EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Optimizing Exosome Lipid Hybrid Nanoparticles for Enhanced siRNA Delivery and Improved Therapeutic Anticancer Efficacy In Vivo

Hend Mohamed Abdel-Bar iD, Steven Tandiono, Revadee Liam-Or, Calvin C L Cheung, Osama W M Hassuneh, Qingyang Lyu, Yue Qin, Shunping Han, Nadia Rouatbi, Julie Tzu-Wen Wang, Adam A Walters, Khuloud T Al-Jamal iD

ACS Nano · 23.12.2025 · 19 (50) · 42658-42674

DOI: 10.1021/acsnano.5c16991 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 11.12.2025. Verfasst von Hend Mohamed Abdel-Bar und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutical Science, King's College London, Franklin-Wilkins Building, 150 Stamford Street, London SE1 9NH, U.K. Hauptthemen laut MEDLINE: Exosomes, Gene Silencing, Liposomes, Nanoparticle Drug Delivery System. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Schlumberger Foundation, King's College London, Brain Tumour Charity.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExosomesGene SilencingLiposomesNanoparticle Drug Delivery SystemNanoparticlesNeoplasmsRNA, Small InterferingAnimalsMiceCD24 AntigenCD47 AntigenHyaluronan ReceptorsMelanoma, Experimental

Stichwörter der Autor:innen

CD24CD44CD47DoEextracellular vesicleslipid nanoparticlestriple negative breast cancer

Substanzen

CD24 AntigenCD47 AntigenHyaluronan ReceptorsLipid NanoparticlesLiposomesNanoparticle Drug Delivery SystemRNA, Small Interfering

Autor:innen und Institutionen

  • Institute of Pharmaceutical Science, King's College London, Franklin-Wilkins Building, 150 Stamford Street, London SE1 9NH, U.K.
  • Department of Pharmaceutics, Faculty of Pharmacy, University of Sadat City, P.O. Box: 32958, Sadat City32897, Egypt.
  • Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong Special Administrative Region999077, China.

ORCID-Profile: Hend Mohamed Abdel-Bar, Khuloud T Al-Jamal

Förderung

  • Schlumberger Foundation
  • King's College London
  • Brain Tumour Charity
  • Research Grants Council, University Grants Committee
  • Brain Research UK
  • Lembaga Pengelola Dana Pendidikan

Zitieren

APA

Abdel-Bar, H. M., Tandiono, S., Liam-Or, R., Cheung, C. C. L., Hassuneh, O. W. M., Lyu, Q., Qin, Y., Han, S., Rouatbi, N., Wang, J. T., Walters, A. A., & Al-Jamal, K. T. (2025). Optimizing Exosome Lipid Hybrid Nanoparticles for Enhanced siRNA Delivery and Improved Therapeutic Anticancer Efficacy In Vivo. ACS Nano, 19(50), 42658-42674. https://doi.org/10.1021/acsnano.5c16991

Vancouver

Abdel-Bar HM, Tandiono S, Liam-Or R, Cheung CCL, Hassuneh OWM, Lyu Q, et al. Optimizing Exosome Lipid Hybrid Nanoparticles for Enhanced siRNA Delivery and Improved Therapeutic Anticancer Efficacy In Vivo. ACS Nano. 2025;19(50):42658-42674. doi:10.1021/acsnano.5c16991

BibTeX
@article{AbdelBar2025,
  author = {Abdel-Bar, Hend Mohamed and Tandiono, Steven and Liam-Or, Revadee and Cheung, Calvin C L and Hassuneh, Osama W M and Lyu, Qingyang and Qin, Yue and Han, Shunping and Rouatbi, Nadia and Wang, Julie Tzu-Wen and Walters, Adam A and Al-Jamal, Khuloud T},
  title = {Optimizing Exosome Lipid Hybrid Nanoparticles for Enhanced siRNA Delivery and Improved Therapeutic Anticancer Efficacy In Vivo},
  journal = {ACS Nano},
  year = {2025},
  volume = {19},
  number = {50},
  pages = {42658--42674},
  doi = {10.1021/acsnano.5c16991}
}
Kostenlos starten →